Calidi Biotherapeutics (CLDI) Exchange Rate Effect (2022 - 2025)
Calidi Biotherapeutics' quarterly Exchange Rate Effect came in at $8000.0 in Q4 2025, down 50.0% year-on-year from $16000.0 in Q4 2024, and down 50.0% quarter-over-quarter from $16000.0 in Q4 2024.
Calidi Biotherapeutics has reported Exchange Rate Effect for 4 years, with the latest figure at $8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 50.0% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2025 stood at -$9000.0 (up 30.77% YoY), and the FY2025 full-year result was $14000.0, up 207.69% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $8000.0, down from $16000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $23000.0 in Q3 2023, with the low at -$33000.0 in Q3 2024.
- Average Exchange Rate Effect over 4 years is $875.0, with a median of $8000.0 recorded in 2022.
- Year-over-year, Exchange Rate Effect slumped 337.5% in 2023 and jumped 184.21% in 2024.
- Tracing CLDI's Exchange Rate Effect over 4 years: stood at $8000.0 in 2022, then tumbled by 337.5% to -$19000.0 in 2023, then jumped by 184.21% to $16000.0 in 2024, then slumped by 50.0% to $8000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $8000.0 (Q4 2025), $16000.0 (Q4 2024), and -$33000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -900,000.00 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -33,000.00 |
| Sep 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |